Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Châu Âu (Europe): $16,729M in FY2025, up 7.5% from a year earlier.
Latest, FY2025
16,729
Period ended Dec 31, 2025
Change on a year earlier
+7.5%
15,557 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Europe | 16 729 | 15 557 | 8 | 4 | 31 | 31”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Châu Âu (Europe) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16,729 | +7.5% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 15,557 | +3.7% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 14,997 | +4.4% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 14,371 | -8.6% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 15,721 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up châu Âu (Europe)
Cite this data
StockData. (2026). Novartis Châu Âu (Europe) ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-europe
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.